N Bergsland1, D Ramasamy2, E Tavazzi2, D Hojnacki3, B Weinstock-Guttman3, R Zivadinov2,4. 1. From the Buffalo Neuroimaging Analysis Center (N.B., D.R., E.T., R.Z.) npbergsland@bnac.net. 2. From the Buffalo Neuroimaging Analysis Center (N.B., D.R., E.T., R.Z.). 3. Jacobs Comprehensive MS Treatment and Research Center (D.H., B.W.-G.), Department of Neurology. 4. Jacobs School of Medicine and Biomedical Sciences, Center for Biomedical Imaging at Clinical Translational Science Institute (R.Z.), University at Buffalo, State University of New York, Buffalo, New York.
Abstract
BACKGROUND AND PURPOSE: Leptomeningeal inflammation is associated with the development of global cortical gray matter atrophy in multiple sclerosis. However, its association with localized loss of tissue remains unclear. The purpose of this study was to evaluate the relationship between leptomeningeal contrast enhancement, a putative marker of leptomeningeal inflammation, and focal cortical thinning in MS. MATERIALS AND METHODS: Forty-three patients with relapsing-remitting MS and 15 with secondary-progressive MS were imaged on a 3T scanner. Cortical reconstruction was performed with FreeSurfer. Leptomeningeal contrast-enhancement foci were visually identified on 3D-FLAIR postcontrast images and confirmed using subtraction imaging. Leptomeningeal contrast-enhancement foci were mapped onto the cortex, and ROIs were obtained by dilating along the surface multiple times (n = 5, 10, 15, 20, 25, 30, 35, 40). Resulting ROIs were then mapped onto the homologous region of the contralateral hemisphere. Paired t tests compared the thickness of the cortex surrounding individual leptomeningeal contrast-enhancement foci and the corresponding contralateral region. Results were corrected for the false discovery rate. RESULTS: Differences between ipsilateral and contralateral ROIs progressively decreased with larger ROIs, but no significant effects were detected when considering the entire MS sample. In patients with relapsing-remitting MS only, significantly reduced cortical thickness was found for 5 dilations (-8.53%, corrected P = .04) and 10 dilations (-5.20%, corrected P = .044). CONCLUSIONS: Focal leptomeningeal contrast enhancement is associated with reduced thickness of the surrounding cortex in patients with relapsing-remitting MS, but not in those with secondary-progressive MS. Our results suggest that pathology associated with the presence of leptomeningeal contrast-enhancement foci has a stronger, localized effect on cortical tissue loss earlier in the disease.
BACKGROUND AND PURPOSE:Leptomeningeal inflammation is associated with the development of global cortical gray matter atrophy in multiple sclerosis. However, its association with localized loss of tissue remains unclear. The purpose of this study was to evaluate the relationship between leptomeningeal contrast enhancement, a putative marker of leptomeningeal inflammation, and focal cortical thinning in MS. MATERIALS AND METHODS: Forty-three patients with relapsing-remitting MS and 15 with secondary-progressive MS were imaged on a 3T scanner. Cortical reconstruction was performed with FreeSurfer. Leptomeningeal contrast-enhancement foci were visually identified on 3D-FLAIR postcontrast images and confirmed using subtraction imaging. Leptomeningeal contrast-enhancement foci were mapped onto the cortex, and ROIs were obtained by dilating along the surface multiple times (n = 5, 10, 15, 20, 25, 30, 35, 40). Resulting ROIs were then mapped onto the homologous region of the contralateral hemisphere. Paired t tests compared the thickness of the cortex surrounding individual leptomeningeal contrast-enhancement foci and the corresponding contralateral region. Results were corrected for the false discovery rate. RESULTS: Differences between ipsilateral and contralateral ROIs progressively decreased with larger ROIs, but no significant effects were detected when considering the entire MS sample. In patients with relapsing-remitting MS only, significantly reduced cortical thickness was found for 5 dilations (-8.53%, corrected P = .04) and 10 dilations (-5.20%, corrected P = .044). CONCLUSIONS: Focal leptomeningeal contrast enhancement is associated with reduced thickness of the surrounding cortex in patients with relapsing-remitting MS, but not in those with secondary-progressive MS. Our results suggest that pathology associated with the presence of leptomeningeal contrast-enhancement foci has a stronger, localized effect on cortical tissue loss earlier in the disease.
Authors: R Zivadinov; D P Ramasamy; J Hagemeier; C Kolb; N Bergsland; F Schweser; M G Dwyer; B Weinstock-Guttman; D Hojnacki Journal: AJNR Am J Neuroradiol Date: 2018-02-08 Impact factor: 3.825
Authors: Claudia F Lucchinetti; Bogdan F G Popescu; Reem F Bunyan; Natalia M Moll; Shanu F Roemer; Hans Lassmann; Wolfgang Brück; Joseph E Parisi; Bernd W Scheithauer; Caterina Giannini; Stephen D Weigand; Jay Mandrekar; Richard M Ransohoff Journal: N Engl J Med Date: 2011-12-08 Impact factor: 91.245
Authors: Martina Absinta; Luisa Vuolo; Anuradha Rao; Govind Nair; Pascal Sati; Irene C M Cortese; Joan Ohayon; Kaylan Fenton; María I Reyes-Mantilla; Dragan Maric; Peter A Calabresi; John A Butman; Carlos A Pardo; Daniel S Reich Journal: Neurology Date: 2015-04-17 Impact factor: 9.910
Authors: Jorge Sepulcre; Joaquín Goñi; Joseph C Masdeu; Bartolome Bejarano; Nieves Vélez de Mendizábal; Juan B Toledo; Pablo Villoslada Journal: Arch Neurol Date: 2009-02
Authors: Roberta Magliozzi; Owain Howell; Abhilash Vora; Barbara Serafini; Richard Nicholas; Maria Puopolo; Richard Reynolds; Francesca Aloisi Journal: Brain Date: 2007-04 Impact factor: 13.501
Authors: Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky Journal: Ann Neurol Date: 2011-02 Impact factor: 10.422
Authors: Gleb Makshakov; Evgeniy Magonov; Natalia Totolyan; Vladimir Nazarov; Sergey Lapin; Alexandra Mazing; Elena Verbitskaya; Tatiana Trofimova; Vladimir Krasnov; Maria Shumilina; Alexander Skoromets; Evgeniy Evdoshenko Journal: Neurol Res Int Date: 2017-10-02
Authors: Keith Carolus; Tom A Fuchs; Niels Bergsland; Deepa Ramasamy; Hoan Tran; Tomas Uher; Dana Horakova; Manuela Vaneckova; Eva Havrdova; Ralph H B Benedict; Robert Zivadinov; Michael G Dwyer Journal: J Neurol Date: 2022-04-08 Impact factor: 6.682
Authors: Whitney M Freeze; Merel van der Thiel; Jeroen de Bresser; Catharina J M Klijn; Ellis S van Etten; Jacobus F A Jansen; Louise van der Weerd; Heidi I L Jacobs; Walter H Backes; Susanne J van Veluw Journal: Neuroimage Clin Date: 2020-10-02 Impact factor: 4.881